Research Summary
A universal nuclease is an enzyme capable of degrading various types of nucleic acids, including DNA and RNA, into smaller fragments. It is widely used in molecular biology, biotechnology, and biopharmaceutical applications to remove unwanted nucleic acids from samples, such as in protein purification, cell lysis, and genomic DNA removal from RNA preparations. Universal nucleases are highly efficient, working under diverse conditions, and are often engineered for enhanced stability and specificity. Their ability to degrade both single-stranded and double-stranded nucleic acids makes them essential in processes like sample cleanup, reducing contamination, and improving the accuracy of downstream applications such as PCR, sequencing, and protein analysis.
According to DIResearch's in-depth investigation and research, the global Universal Nuclease market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Universal Nuclease include Thermo Fisher Scientific Inc., RayBiotech, Inc., TransGen Biotech, AbMole BioScience, Yisheng Biotechnology (Shanghai), GenScript, Shanghai Biyuntian Biotechnology, KACTUS, Shanghai Zhudian Biotechnology, ACROBiosystems Group, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Universal Nuclease. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Universal Nuclease market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Universal Nuclease market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Universal Nuclease industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Universal Nuclease Include:
Thermo Fisher Scientific Inc.
RayBiotech, Inc.
TransGen Biotech
AbMole BioScience
Yisheng Biotechnology (Shanghai)
GenScript
Shanghai Biyuntian Biotechnology
KACTUS
Shanghai Zhudian Biotechnology
ACROBiosystems Group
Universal Nuclease Product Segment Include:
5kU
25kU
50kU
100kU
＞100kU
Universal Nuclease Product Application Include:
Biological Laboratory
University Research Room
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Universal Nuclease Industry PESTEL Analysis
Chapter 3: Global Universal Nuclease Industry Porter’s Five Forces Analysis
Chapter 4: Global Universal Nuclease Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Universal Nuclease Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Universal Nuclease Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Universal Nuclease Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Universal Nuclease Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Universal Nuclease Product by Type
- 1.2.1 5kU
- 1.2.2 25kU
- 1.2.3 50kU
- 1.2.4 100kU
- 1.2.5 ＞100kU
- 1.3 Universal Nuclease Product by Application
- 1.3.1 Biological Laboratory
- 1.3.2 University Research Room
- 1.3.3 Others
- 1.4 Global Universal Nuclease Market Revenue and Sales Analysis
- 1.4.1 Global Universal Nuclease Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Universal Nuclease Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Universal Nuclease Market Sales Price Trend Analysis (2020-2032)
- 1.5 Universal Nuclease Industry Trends and Innovation
- 1.5.1 Universal Nuclease Industry Trends and Innovation
- 1.5.2 Universal Nuclease Market Drivers and Challenges
- 2 Universal Nuclease Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Universal Nuclease Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Universal Nuclease Market Analysis by Regions
- 4.1 Universal Nuclease Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Universal Nuclease Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Universal Nuclease Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Universal Nuclease Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Universal Nuclease Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Universal Nuclease Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Universal Nuclease Sales Forecast by Region (2026-2032)
- 4.4 Global Universal Nuclease Sales Price Trend Analysis (2020-2032)
- 5 Global Universal Nuclease Market Size by Type and Application
- 5.1 Global Universal Nuclease Market Size by Type
- 5.1.1 Global Universal Nuclease Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Universal Nuclease Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Universal Nuclease Market Size by Application
- 5.2.1 Global Universal Nuclease Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Universal Nuclease Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Universal Nuclease Market Size by Type
- 6.3.1 North America Universal Nuclease Sales by Type (2020-2032)
- 6.3.2 North America Universal Nuclease Revenue by Type (2020-2032)
- 6.4 North America Universal Nuclease Market Size by Application
- 6.4.1 North America Universal Nuclease Sales by Application (2020-2032)
- 6.4.2 North America Universal Nuclease Revenue by Application (2020-2032)
- 6.5 North America Universal Nuclease Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Universal Nuclease Market Size by Type
- 7.3.1 Europe Universal Nuclease Sales by Type (2020-2032)
- 7.3.2 Europe Universal Nuclease Revenue by Type (2020-2032)
- 7.4 Europe Universal Nuclease Market Size by Application
- 7.4.1 Europe Universal Nuclease Sales by Application (2020-2032)
- 7.4.2 Europe Universal Nuclease Revenue by Application (2020-2032)
- 7.5 Europe Universal Nuclease Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Universal Nuclease Market Size by Type
- 8.3.1 China Universal Nuclease Sales by Type (2020-2032)
- 8.3.2 China Universal Nuclease Revenue by Type (2020-2032)
- 8.4 China Universal Nuclease Market Size by Application
- 8.4.1 China Universal Nuclease Sales by Application (2020-2032)
- 8.4.2 China Universal Nuclease Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Universal Nuclease Market Size by Type
- 9.3.1 APAC (excl. China) Universal Nuclease Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Universal Nuclease Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Universal Nuclease Market Size by Application
- 9.4.1 APAC (excl. China) Universal Nuclease Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Universal Nuclease Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Universal Nuclease Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Universal Nuclease Market Size by Type
- 10.3.1 Latin America Universal Nuclease Sales by Type (2020-2032)
- 10.3.2 Latin America Universal Nuclease Revenue by Type (2020-2032)
- 10.4 Latin America Universal Nuclease Market Size by Application
- 10.4.1 Latin America Universal Nuclease Sales by Application (2020-2032)
- 10.4.2 Latin America Universal Nuclease Revenue by Application (2020-2032)
- 10.5 Latin America Universal Nuclease Market Size by Country
- 10.6 Latin America Universal Nuclease Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Universal Nuclease Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Universal Nuclease Market Size by Type
- 11.3.1 Middle East & Africa Universal Nuclease Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Universal Nuclease Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Universal Nuclease Market Size by Application
- 11.4.1 Middle East & Africa Universal Nuclease Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Universal Nuclease Revenue by Application (2020-2032)
- 11.5 Middle East Universal Nuclease Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Universal Nuclease Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Universal Nuclease Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Universal Nuclease Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Universal Nuclease Average Sales Price by Manufacturers (2021-2025)
- 12.2 Universal Nuclease Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Universal Nuclease Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Thermo Fisher Scientific Inc.
- 13.1.1 Thermo Fisher Scientific Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolio
- 13.1.3 Thermo Fisher Scientific Inc. Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 RayBiotech, Inc.
- 13.2.1 RayBiotech, Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 RayBiotech, Inc. Universal Nuclease Product Portfolio
- 13.2.3 RayBiotech, Inc. Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 TransGen Biotech
- 13.3.1 TransGen Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 TransGen Biotech Universal Nuclease Product Portfolio
- 13.3.3 TransGen Biotech Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 AbMole BioScience
- 13.4.1 AbMole BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 AbMole BioScience Universal Nuclease Product Portfolio
- 13.4.3 AbMole BioScience Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Yisheng Biotechnology (Shanghai)
- 13.5.1 Yisheng Biotechnology (Shanghai) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Yisheng Biotechnology (Shanghai) Universal Nuclease Product Portfolio
- 13.5.3 Yisheng Biotechnology (Shanghai) Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 GenScript
- 13.6.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 GenScript Universal Nuclease Product Portfolio
- 13.6.3 GenScript Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Shanghai Biyuntian Biotechnology
- 13.7.1 Shanghai Biyuntian Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Shanghai Biyuntian Biotechnology Universal Nuclease Product Portfolio
- 13.7.3 Shanghai Biyuntian Biotechnology Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 KACTUS
- 13.8.1 KACTUS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 KACTUS Universal Nuclease Product Portfolio
- 13.8.3 KACTUS Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Shanghai Zhudian Biotechnology
- 13.9.1 Shanghai Zhudian Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Shanghai Zhudian Biotechnology Universal Nuclease Product Portfolio
- 13.9.3 Shanghai Zhudian Biotechnology Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 ACROBiosystems Group
- 13.10.1 ACROBiosystems Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 ACROBiosystems Group Universal Nuclease Product Portfolio
- 13.10.3 ACROBiosystems Group Universal Nuclease Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Universal Nuclease Industry Chain Analysis
- 14.2 Universal Nuclease Industry Raw Material and Suppliers Analysis
- 14.2.1 Universal Nuclease Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Universal Nuclease Typical Downstream Customers
- 14.4 Universal Nuclease Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook